analgesic/hemorrhage

STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT (Not Applicable) REFERENCE TO A SEQUENCE LISTING, A TABLE, OR A COMPUTER PROGRAM LISTING APPENDIX SUBMITTED ON COMPACT DISC (SEE 37 CFR 1.52(e)(5)) (Not Applicable) BACKGROUND OF THE INVENTION 1. Field of the Invention The invention

FIELD OF THE INVENTION This invention relates to pharmaceutical compositions of the d,l- or l-lysine salt of R,S or S-ibuprofen having analgesic, anti-inflammatory and anti-pyretic activity. The invention further relates to a method of treating pain or inflammation or of reducing fever by

FIELD OF THE INVENTION The invention relates to novel compositions and process for preparation of such compositions comprising an extract of the plant Euphorbia prostrata useful for the treatment of anorectal diseases including hemorrhoids, and colonic diseases. The novel compositions possess

BACKGROUND OF THE INVENTION 1. Field of the Invention The decrease or reduction of toxicity, and the inhibition of ulcerogenesis and bleeding in the stomach, due to the ingestion of a pharmaceutically effective concentration or dosage of aspirin. 2. Description of the Prior Art The extensive use of

FIELD OF THE INVENTION The present invention is directed to pharmaceutical compositions that provide for the coordinated release of an acid inhibitor and a non-steroidal anti-inflammatory drug (NSAID). These compositions have a reduced likelihood of causing unwanted side effects, especially

FIELD OF THE INVENTION The present invention is directed to pharmaceutical compositions that provide for the coordinated release of an acid inhibitor and a non-steroidal anti-inflammatory drug (NSAID). These compositions; have a reduced likelihood of causing unwanted side effects, especially

FIELD OF THE INVENTION The present invention is directed to pharmaceutical compositions that provide for the coordinated release of an acid inhibitor and a non-steroidal anti-inflammatory drug (NSAID). These compositions have a reduced likelihood of causing unwanted side effects, especially

FIELD OF THE INVENTION The present invention is directed to pharmaceutical compositions that provide for the coordinated release of an acid inhibitor and a non-steroidal anti-inflammatory drug (NSAID). These compositions have a reduced likelihood of causing unwanted side effects, especially

FIELD OF THE INVENTION The present invention is directed to pharmaceutical compositions that provide for the coordinated release of an acid inhibitor and a non-steroidal anti-inflammatory drug (NSAID). These compositions have a reduced likelihood of causing unwanted side effects, especially

FIELD OF THE INVENTION The present invention is directed to pharmaceutical compositions that provide for the coordinated release of an acid inhibitor and a non-steroidal anti-inflammatory drug (NSAID). These compositions have a reduced likelihood of causing unwanted side effects, especially

FIELD OF THE INVENTION The present invention is directed to pharmaceutical compositions that provide for the coordinated release of an acid inhibitor and a non-steroidal anti-inflammatory drug (NSAID). These compositions have a reduced likelihood of causing unwanted side effects, especially

FIELD OF THE INVENTION The present invention is directed to pharmaceutical compositions that provide for the coordinated release of an acid inhibitor and a non-steroidal anti-inflammatory drug (NSAID). These compositions have a reduced likelihood of causing unwanted side effects, especially

FIELD OF THE INVENTION The present invention is directed to pharmaceutical compositions that provide for the coordinated release of an acid inhibitor and a non-steroidal anti-inflammatory drug (NSAID). These compositions; have a reduced likelihood of causing unwanted side effects, especially